AKT1 and cancer: Previous studies have reported the inhibitory roles of quercetin on the growth, survival, metastasis, and chemotherapy and radiotherapy resistance of LC cells via cancer pathways such as Akt, MAPKs, NF-κB, inflammation, and apoptotic caspase signaling [203–209].